Androgen Receptor Gene Overexpression Terminated Phase 2 Trials for Prasterone (DB01708)
Indication | Status | Phase |
---|---|---|
DBCOND0067050 (Androgen Receptor Gene Overexpression) | Terminated | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT02000375 | A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT) | Treatment |